Skip to main content
. 2017 Apr 24;8(4):397–401. doi: 10.1007/s13340-017-0320-4

Fig. 1.

Fig. 1

Changes in blood pressure, eGFR and serum uric acid concentration before and after switching from sitagliptin to linagliptin. Abbreviations are shown in the text. Data are expressed as mean ± SD. Repeated measures ANOVA with post hoc Bonferroni test was used for statistical analysis. *P < 0.05, **P < 0.01, ***P < 0.001 versus the value at switching from sitagliptin to linagliptin. # P < 0.05, P < 0.01, †† P < 0.001 versus the value at the initiation of sitagliptin